The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy
Launched by CASE WESTERN RESERVE UNIVERSITY · Mar 31, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective a mobile phone app is for helping people with obstructive sleep apnea (OSA) compared to using a printed guide. Obstructive sleep apnea is a condition that causes breathing problems during sleep, often leading to snoring and poor sleep quality. The study aims to see if doing specific airway exercises using the app can improve sleep and reduce snoring for those who have not had success with other treatments, like CPAP machines.
To join the study, participants should be between the ages of 18 and 75 and have mild to severe OSA. However, there are some conditions that would exclude someone from participating, such as having a very high body weight, certain heart or neurological conditions, or problems that restrict tongue movement. If eligible, participants will be asked to follow along with the app or the printed guide and report on how their sleep and snoring improve over time. This trial is currently recruiting, so there’s an opportunity for those struggling with OSA to find a potentially helpful solution.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with mild, moderate, and severe OSA who rejected/failed CPAP or other therapeutic options will be invited to participate in the study.
- Exclusion Criteria:
- • 1. Age lower than 18 or higher than 75.
- • 2. BMI \> 40
- • 3. Alcoholism or drug abuse
- • 4. A-fib, pacemaker, CHF, strokes, narcotics
- • 5. Neuromuscular disease
- • 6. Use of benzodiazepine hypnotics (may affect muscle tone)
- • 7. Restricted tongue movement
- • 8. Permanently blocked nose
- • 9. TMJ disorder.
- • 10. Lost to follow-up
- • 11. Gained or lost ≥5% of body weight during 3 months
About Case Western Reserve University
Case Western Reserve University (CWRU) is a leading research institution located in Cleveland, Ohio, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, CWRU integrates expertise from various fields, including medicine, engineering, and social sciences, to address complex health challenges. The university's clinical trial initiatives are designed to foster the development of novel therapies and interventions, ensuring rigorous scientific methodologies and ethical standards are upheld. CWRU is dedicated to translating research findings into tangible benefits for patients and communities, contributing significantly to the advancement of healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Juan M Palomo, DDS, MSD
Principal Investigator
Case Western Reserve University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported